JP2024528081A5 - - Google Patents
Info
- Publication number
- JP2024528081A5 JP2024528081A5 JP2024505372A JP2024505372A JP2024528081A5 JP 2024528081 A5 JP2024528081 A5 JP 2024528081A5 JP 2024505372 A JP2024505372 A JP 2024505372A JP 2024505372 A JP2024505372 A JP 2024505372A JP 2024528081 A5 JP2024528081 A5 JP 2024528081A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- composition according
- monoclonal antibody
- precancerous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163226699P | 2021-07-28 | 2021-07-28 | |
| US63/226,699 | 2021-07-28 | ||
| US202163250725P | 2021-09-30 | 2021-09-30 | |
| US63/250,725 | 2021-09-30 | ||
| PCT/US2021/056259 WO2022087416A1 (en) | 2020-10-22 | 2021-10-22 | Combination radioimmunotherapy and cd47 blockade in the treatment of cancer |
| USPCT/US2021/056259 | 2021-10-22 | ||
| US17/702,648 US20220211886A1 (en) | 2020-10-22 | 2022-03-23 | Combination radioimmunotherapy and cd47 blockade in the treatment of cancer |
| US17/702,648 | 2022-03-23 | ||
| PCT/US2022/025655 WO2023009189A1 (en) | 2021-07-28 | 2022-04-20 | Combination radioimmunotherapy and cd47 blockade in the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528081A JP2024528081A (ja) | 2024-07-26 |
| JP2024528081A5 true JP2024528081A5 (https=) | 2025-04-23 |
Family
ID=85087177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024505372A Pending JP2024528081A (ja) | 2021-07-28 | 2022-04-20 | 癌の治療における放射免疫療法及びｃｄ４７遮断薬の組み合わせ |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4376856A1 (https=) |
| JP (1) | JP2024528081A (https=) |
| CA (1) | CA3227223A1 (https=) |
| WO (1) | WO2023009189A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117915938A (zh) * | 2021-06-30 | 2024-04-19 | 俄亥俄州国家创新基金会 | 用于与抗cd47-sirpα治疗剂组合抑制二氢乳清酸脱氢酶的方法和组合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112245586A (zh) * | 2013-03-15 | 2021-01-22 | 小利兰·斯坦福大学托管委员会 | 用于实现治疗有效剂量的抗cd47剂的方法 |
| WO2019136422A1 (en) * | 2018-01-08 | 2019-07-11 | Actinum Pharmaceuticals, Inc. | Combination immunotherapy and chemotherapy for the treatment of a hematological malignancy |
-
2022
- 2022-04-20 JP JP2024505372A patent/JP2024528081A/ja active Pending
- 2022-04-20 WO PCT/US2022/025655 patent/WO2023009189A1/en not_active Ceased
- 2022-04-20 CA CA3227223A patent/CA3227223A1/en active Pending
- 2022-04-20 EP EP22850033.6A patent/EP4376856A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Runcie et al. | Bi-specific and tri-specific antibodies-the next big thing in solid tumor therapeutics | |
| Zhang et al. | Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR | |
| Kozani et al. | Novel antigens of CAR T cell therapy: New roads; old destination | |
| JP2021523192A5 (https=) | ||
| Scott et al. | Antibody-based immunological therapies | |
| Gan et al. | Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy | |
| JP2023519974A5 (https=) | ||
| JP2021525731A5 (https=) | ||
| Han et al. | The old CEACAMs find their new role in tumor immunotherapy | |
| RU2020120411A (ru) | Триспецифические связывающие молекулы, направленные против опухолеассоциированных антигенов, и пути их применения | |
| JP2021535142A5 (https=) | ||
| JP2018537516A5 (https=) | ||
| WO2018121605A1 (zh) | 一种多功能蛋白质 | |
| WO2022216965A1 (en) | Radioimmunotherapy directed to ccr8 for depletion of tumor infiltrating regulatory t cells | |
| JP2024520676A5 (https=) | ||
| JP2019534705A (ja) | 抗ｉｌ１−ｒａｐ抗体 | |
| JP2024531446A5 (https=) | ||
| JP2023550148A5 (https=) | ||
| JP2024528081A5 (https=) | ||
| Zhang et al. | Recent progress on therapeutic vaccines for breast cancer | |
| JP2024530166A5 (https=) | ||
| Huppert et al. | Emerging immunotherapeutic strategies for the treatment of breast cancer | |
| CN100588662C (zh) | 癌症疾病改善抗体 | |
| Mardomi et al. | Matrix metalloproteinase 8: Could it benefit the CAR-T cell therapy of solid tumors?-a-Commentary on therapeutic potential | |
| JP2025515324A5 (https=) |